Jaundice in the newborns.
Hyperbilirubinemia is the commonest morbidity in the neonatal period and 5-10% of all newborns require intervention for pathological jaundice. Neonates on exclusive breast-feeding have a different pattern and degree of jaundice as compared to artificially fed babies. Latest guidelines from the American Academy of Pediatrics (AAP) for management of jaundice in a normal term newborn have been included in the protocol. Separate guidelines have been provided for the management of jaundice in sick term babies, preterm and low birth weight babies, for hemolytic jaundice and prolonged hyperbilirubinemia.
Mishra
Satish
S
Division of Neonatology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Agarwal
Ramesh
R
Deorari
Ashok K
AK
Paul
Vinod K
VK
D000927:Anticonvulsants / Q000627:therapeutic use; D001663:Bilirubin / Q000032:analysis / Q000097:blood; D004359:Drug Therapy, Combination; D005078:Exchange Transfusion, Whole Blood / Q000379:methods; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007567:Jaundice, Neonatal / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D010634:Phenobarbital / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
D000927:Anticonvulsants; D007136:Immunoglobulins; D007155:Immunologic Factors; D001663:Bilirubin; D010634:Phenobarbital